Related Experiment Video
Updated: Jan 27, 2026
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Risk factors and clinical implications of thyroxine replacement therapy on major adverse cardiovascular events in
Chih-Wei Hsu1, Chia-Hung Lin1,2, Pi-Hua Liu1,3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan.
Background:
Thyroid hormone replacement therapy is widely used to treat hypothyroidism, but there is limited research on its effects in patients with diabetes mellitus (DM). Some studies indicate that this therapy might improve lipid profiles in DM patients, but even with normalized TSH levels from thyroxine replacement, LDL and total cholesterol levels remain higher than in people with normal thyroid function. Additionally, the effect of this therapy on major adverse cardiovascular events (MACE) in DM patients is still uncertain.
Aim:
This retrospective study investigated the occurrence of major adverse cardiovascular events (MACE) in participants receiving thyroxine with diabetes and compared the risk factors between the MACE and non-MACE groups.
Methods:
We used longitudinal claims data from 2008 to 2017 from the Chang Gung Research Database. Individuals with diabetes who used thyroxine were included. The primary outcome was the occurrence of MACE. The secondary outcomes were the differences between the two groups (MACE vs. no MACE).
Results:
After 1:1 group matching by propensity score between MACE and non-MACE groups by sex, age, and interval of using thyroxine, there were 416 patients in each group. Patients with worse renal function (eGFR <45 ml/min/1.73 m2), hypertension, history of diabetic microvascular complications, end-stage renal disease (ESRD), coronary heart disease (CHD), heart failure, cerebrovascular accident (CVA), and diabetic foot infection had a higher risk of experiencing MACE. Free T4 had a weak positive correlation with HDL, and TSH had a weak positive correlation with LDL and a negative correlation with HDL (correlation coefficient, p-value: 0.131, 0.022; 0.124, 0.016; and -0.157, 0.003, respectively). There were no optimal cutoff points according to the receiver operating characteristic (ROC) curve analysis of the best discrimination point between TSH/free T4/LDL and MACE attack.
Conclusions:
In participants receiving thyroxine with diabetes, patients with worse renal function, hypertension, history of diabetic microvascular complications, ESRD, CHD, heart failure, CVA, and diabetic foot infection had a higher risk of experiencing MACE, but peripheral artery disease (PAD) was not a significant risk of MACE.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:30Continuous Renal Replacement Therapy
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
01:17Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...